Search

Your search keyword '"Pesavento, R"' showing total 354 results

Search Constraints

Start Over You searched for: Author "Pesavento, R" Remove constraint Author: "Pesavento, R"
354 results on '"Pesavento, R"'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

3. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

4. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

5. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

6. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

7. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

8. Timing and characteristics of venous thromboembolism after noncancer surgery

9. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

10. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

11. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

13. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

14. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

15. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

16. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

18. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

19. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

20. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

21. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

22. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

23. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

24. DVT Management and Outcome Trends, 2001 to 2014

25. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

27. Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation

28. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

29. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

30. D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

31. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

32. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

33. Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation

34. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

35. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

38. Meta-analyses of sulodexide and other drugs in prevention and treatment of post-thrombotic syndrome.

40. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

41. D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

42. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

43. Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation

44. Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation (Journal of Thrombosis and Thrombolysis, (2021), 52, 3, (772-778), 10.1007/s11239-021-02429-z)

45. Timing and characteristics of venous thromboembolism after noncancer surgery

46. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering

47. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study

48. A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs

Catalog

Books, media, physical & digital resources